Supreme Court rules against Stanford in patent dispute
The U.S. Supreme Court on Monday sided with a drug company over Stanford University in a patent dispute.
Brandeis and 53 fellow members of the Association of American Universities (AAU) had urged the Supreme Court to reverse an appeals court decision granting rights to Roche Molecular Systems for federally-funded research conducted at Stanford, but the court ruled 7-2 against the university.
Following the decision, the AAU and the Biotechnology Industry Organization (BIO) issued a joint statement on continued collaboration.
"Although BIO and the undersigned higher education associations held different views on the Stanford v. Roche case, the organizations are united in the desire to ensure that the U.S. technology transfer system continues to generate these public benefits through the robust provisions of the Bayh-Dole statute," it read. "We are committed to working together in light of the Supreme Court's decision to ensure the continued vibrancy of public-private partnerships and success of our shared objectives."